{"id":"https://openalex.org/W4388043234","doi":"https://doi.org/10.3389/fonc.2023.1210224","title":"Network-targeting combination therapy of leptomeningeal glioblastoma using multiple synthetic lethal strategies: a case report","display_name":"Network-targeting combination therapy of leptomeningeal glioblastoma using multiple synthetic lethal strategies: a case report","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388043234","doi":"https://doi.org/10.3389/fonc.2023.1210224","pmid":"https://pubmed.ncbi.nlm.nih.gov/38023264","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10644375"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2023.1210224","doi":"https://doi.org/10.3389/fonc.2023.1210224","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2023.1210224","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2023.1210224/pdf?isPublishedV2=False","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2023.1210224/pdf?isPublishedV2=False","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014677392","display_name":"Michael P Castro","orcid":"https://orcid.org/0000-0003-0421-1027","observed_orcids":["https://orcid.org/0000-0003-0421-1027"]},"institutions":[{"id":"https://openalex.org/I4210100502","display_name":"Beverly Hills Cancer Center","ror":"https://ror.org/00j1j3213","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210100502"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael P. Castro","raw_affiliation_strings":["Beverly Hills Cancer Center, Beverly Hills, CA, United States","Cellworks Group, Inc, San Francisco, CA, United States","Personalized Cancer Medicine, PLLC, Santa Monica, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beverly Hills Cancer Center, Beverly Hills, CA, United States","institution_ids":["https://openalex.org/I4210100502"]},{"raw_affiliation_string":"Cellworks Group, Inc, San Francisco, CA, United States","institution_ids":[]},{"raw_affiliation_string":"Personalized Cancer Medicine, PLLC, Santa Monica, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023421590","display_name":"Bence Sipos","orcid":"https://orcid.org/0000-0002-7311-3343","observed_orcids":["https://orcid.org/0000-0002-7311-3343"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bence Sipos","raw_affiliation_strings":["Department of Pathology, Molekularpathologie Baden-W\u00fcrttemberg GbR, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Molekularpathologie Baden-W\u00fcrttemberg GbR, Tuebingen, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052522766","display_name":"Saskia Biskup","orcid":"https://orcid.org/0000-0002-1573-861X","observed_orcids":["https://orcid.org/0000-0002-1573-861X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saskia Biskup","raw_affiliation_strings":["Center for Genomics & Transcriptomics, GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Genomics & Transcriptomics, GmbH, Tuebingen, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111064723","display_name":"Nina Kahn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nina Kahn","raw_affiliation_strings":["Independent Researcher, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Independent Researcher, Amsterdam, Netherlands","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5014677392"],"corresponding_institution_ids":["https://openalex.org/I4210100502"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":0.2406,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.47422543,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"13","issue":null,"first_page":"1210224","last_page":"1210224"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.8870000243186951},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.9929999709129333},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.8920000195503235},{"id":"https://openalex.org/keywords/redox-homeostasis","display_name":"redox homeostasis","score":0.9020000100135803},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9100000262260437},{"id":"https://openalex.org/keywords/lomustine","display_name":"lomustine","score":0.9300000071525574},{"id":"https://openalex.org/keywords/digoxin","display_name":"digoxin","score":0.9319999814033508},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":1.0}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7654827833175659},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.6419214010238647},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.5868628025054932},{"id":"https://openalex.org/C2779434656","wikidata":"https://www.wikidata.org/wiki/Q415378","display_name":"Lomustine","level":5,"score":0.5563758015632629},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.49312493205070496},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4205661416053772},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.41523897647857666},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37866103649139404},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36531051993370056},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3495182394981384},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29993876814842224},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2754492163658142},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2561165392398834},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.1328037977218628},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.0995320975780487},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09230098128318787},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.08478313684463501},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2023.1210224","doi":"https://doi.org/10.3389/fonc.2023.1210224","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2023.1210224","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2023.1210224/pdf?isPublishedV2=False","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10644375","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10644375","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10644375/pdf/fonc-13-1210224.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:38023264","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38023264","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Case Reports"},{"id":"pmh:oai:doaj.org/article:870afce3373c406ab1cd7452ac187cd0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/870afce3373c406ab1cd7452ac187cd0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 13 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2023.1210224","doi":"https://doi.org/10.3389/fonc.2023.1210224","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2023.1210224","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2023.1210224/pdf?isPublishedV2=False","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388043234.pdf","grobid_xml":"https://content.openalex.org/works/W4388043234.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1988310632","https://openalex.org/W2011480745","https://openalex.org/W2062468930","https://openalex.org/W2109816625","https://openalex.org/W2604812571","https://openalex.org/W2737417319","https://openalex.org/W2811060920","https://openalex.org/W2950931626","https://openalex.org/W2953228415","https://openalex.org/W2983649157","https://openalex.org/W2994990079","https://openalex.org/W3027364034","https://openalex.org/W3036597250","https://openalex.org/W3101338849","https://openalex.org/W3195223672","https://openalex.org/W3195306241","https://openalex.org/W3211380190","https://openalex.org/W3216085448","https://openalex.org/W4220865729","https://openalex.org/W4220939635","https://openalex.org/W4224994455","https://openalex.org/W4281900516","https://openalex.org/W4286296229","https://openalex.org/W4292265230","https://openalex.org/W4298048783","https://openalex.org/W6809653769"],"related_works":["https://openalex.org/W4389521868","https://openalex.org/W4409082796","https://openalex.org/W4392593184","https://openalex.org/W6908519234","https://openalex.org/W2116631246","https://openalex.org/W2887401922","https://openalex.org/W4399498153","https://openalex.org/W6991254535","https://openalex.org/W3028118552","https://openalex.org/W2809528705"],"abstract_inverted_index":{"Network":[0],"targeting":[1],"of":[2,17,31,62,77],"disease-specific":[3,38],"nodes":[4],"represents":[5],"a":[6,18,32,52,91],"useful":[7],"principle":[8,76],"for":[9],"designing":[10],"combination":[11,55],"cancer":[12],"therapy.":[13],"In":[14],"this":[15],"case":[16],"patient":[19],"with":[20,85],"relapsed":[21],"leptomeningeal":[22],"glioblastoma,":[23],"comprehensive":[24],"molecular":[25],"diagnosis":[26],"led":[27],"to":[28,81,89],"the":[29,75,83],"identification":[30],"disease":[33],"network":[34],"characterized":[35],"by":[36],"multiple":[37],"synthetic":[39],"lethal":[40],"vulnerabilities":[41],"involving":[42],"DNA":[43],"repair,":[44],"REDOX":[45],"homeostasis,":[46],"and":[47,67],"impaired":[48],"autophagy":[49],"which":[50],"suggested":[51],"novel":[53],"network-targeting":[54],"therapy":[56],"(NTCT).":[57],"A":[58],"treatment":[59,84],"regimen":[60],"consisting":[61],"lomustine,":[63],"olaparib,":[64],"digoxin,":[65],"metformin,":[66],"high":[68],"dose":[69,79],"intravenous":[70],"ascorbate":[71],"was":[72],"employed":[73],"using":[74],"intra-patient":[78],"escalation":[80],"deliver":[82],"adequate":[86],"safety":[87],"measures":[88],"achieve":[90],"definitive":[92],"clinical":[93],"result.":[94]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-11-01T00:00:00"}